JAK2 V617F基因突变检测技术新进展
摘要
JAK2V617F突变是Ph(-)的慢性骨髓增殖性疾病(MPD)诊断标准之一,目前检测JAK2V617F突变的方法很多,为临床疾病的诊断及治疗提供了可靠的分子依据。本文对近年关于JAK2V617F突变检测方法的特点、具体操作流程及进展予以综述。
出处
《医学理论与实践》
2014年第8期1019-1021,1115,共4页
The Journal of Medical Theory and Practice
参考文献15
-
1Baxter EJ, Scott LM, Campbeu P J, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative diseases [J]. Lancet,2005, 365 : 1054-1061.
-
2Steensma DP. JAK2 V617 F in myeloid disorders: molecular di- agnostic techniques and their clinical utility[J]. Journal of Mo-lecular Diagnostics, 2006,8(4) : 397-411.
-
3Nelson ME, Steensma DP. JAK2 V617F in myeloid disorders: what do we know now, and where are we headed[J]. Leuk Lymphoma, 2006,47:177-194.
-
4Tefferi A Gilliland IX;. The JAK2V617F tyrosine kinase muta- tion in myeloproliferative disorders: status report and immedi- ate implications for disease classification and diagnosis[J]. Mayo Clin Proe, 2005,80: 947-958.
-
5Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leuke- mia: rationale and important changes[J]. Blood, 2009,114: 937- 951.
-
6. Ma W, Kantarjian H, zhang X, et al. Higher detection rate of JAK2 mutation using plasma[J]. Blood,2008,111(7): 3906- 3907.
-
7Xu X, Zhang Q, Luo J, et al. AK2 (V617F): Prevalence in a large Chinese hospital population[J]. Blood, 2007, 109 (1) : 339-342.
-
8Kaltenboeck B, Wang C. Advances in real-time PCR: applica- tion to clinical laboratory diagnostics [J]. Adv Clin Chem, 2005,40: 219-259.
-
9Frayling IM ME. PCR-based methods for mutation detection. Molecular Diagnostics for the Clinical Laboratorian[J]. Huma- na Press, 2006 : 65-74.
-
10McClure R,Mai M, Lasho T. Validation of two clinically use- ful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders[J]. Leukemia, 2006,20:168-171.
-
1成志勇,付建珠,徐倩,赵亚玲,刘桂敏,卞永生,梁丽青,万建设,张丽军.PTEN、VEGF、COX-2与JAK2 V617F突变阳性骨髓增殖性肿瘤血管新生[J].中国病理生理杂志,2016,32(5):938-942. 被引量：9
-
2谢维.聚合酶链反应技术新进展[J].解放军医学情报,1991,5(3):139-141.
-
3陈洁晶,黎莉,刘丽新,汪亚东.大肠杆菌O_(157):H_7实验诊断技术新进展[J].实用预防医学,2000,7(1):74-75.
-
4薛生,朱元晓,沈倍奋.单克隆抗体技术新进展[J].国外医学（免疫学分册）,1993,16(4):196-200. 被引量：6
-
5邢晓为,傅俊江,李麓芸.SSCP突变分析技术新进展[J].国外医学（遗传学分册）,2001,24(6):296-297. 被引量：6
-
6郑卫东,方伟,刘艳辉,罗盈,杜欣,陈志红.高分辨率熔解曲线法检测JAK2基因V617F突变及其应用[J].临床检验杂志,2011,29(8):602-604. 被引量：1
-
7刘贵敏,张丽军,王红杰,韩颖,付建珠,赵强,梁文同,成志勇.MMP-2、MMP-9在JAK2 V617F阳性的骨髓增殖性肿瘤中表达增强[J].细胞与分子免疫学杂志,2017,33(3):372-375. 被引量：4
-
8胡国瑜,邓明扬,张广森,骆云雅,朱剑锋.骨髓增殖性疾病患者JAK2基因V617F突变频率、磷酸化JAK／STAT蛋白表达水平及临床意义[J].中华血液学杂志,2009,30(6):394-398. 被引量：6
-
9胡晓燕,李颂,梅陵宣.变形链球菌分子生物学鉴定技术新进展[J].国际口腔医学杂志,2006,33(5):346-348. 被引量：1
-
10江晓玲,徐伟支,李明.荧光定量PCR技术新进展[J].广东寄生虫学会年报,1999,21(1):55-57.
